Boehringer Ingelheim Pharmaceuticals Inc. et al v. Biocon Limited et al > Summary
Court Case Number 1:25-cv-00523
Filing Date Apr 30, 2025
Termination Date Oct 28, 2025
Court Delaware District Court
Status Unknown
JudgesColm F. Connolly
Plaintiff Attorneys
6Boehringer Ingelheim International GmbH
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Defendant Attorneys
6Biocon Pharma, Inc.
Attorney Name: Neal C. Belgam
Smith, Katzenstein & Jenkins LLP
Biocon Pharma, Inc.
Attorney Name: Daniel A. Taylor
Smith, Katzenstein & Jenkins LLP
Biocon Pharma, Inc.
Attorney Name: Neal C. Belgam
Smith, Katzenstein & Jenkins LLP
Biocon Pharma, Inc.
Attorney Name: Daniel A. Taylor
Smith, Katzenstein & Jenkins LLP
Biocon Pharma, Inc.
Attorney Name: Neal C. Belgam
Smith, Katzenstein & Jenkins LLP
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11911388 | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug | Feb 27, 2024 |
| 10034877 | Treatment for diabetes in patients inappropriate for metformin therapy | Jul 31, 2018 |
| 09486526 | Treatment for diabetes in patients inappropriate for metformin therapy | Nov 8, 2016 |
| 08853156 | Treatment for diabetes in patients inappropriate for metformin therapy | Oct 7, 2014 |
